AT307576T
Process of manufacturing Fenofibrate pharmaceutical compositions with a higher bioavailability
Abstract
The invention relates to a composition of fenofibrate immediate release comprising a support inert water-soluble form of fenofibrate micronized having a lower particle size or equal to about 20 microns, having a dissolution of at least 10% in 5 minutes, 20% in 10 minutes, 50% by 20 minutes and 75% in 30 minutes, as measured according to the method of the rotary vane 75 t / min according to the European Pharmacopoeia, in a medium dissolution constituted by water with 2% by weight polysorbate 80 or 0.025M of sodium lauryl sulphate. The invention further relates to a method for preparation.
Term
Term ended
Expired 16 January 2018, 8.7 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
144 members in 37 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 9700479 | France | A |
Members144
| Document | Office | Kind | |
|---|---|---|---|
| CA2219475A1 | Canada | A1 | |
| CA2372561A1 | Canada | A1 | |
| CA2372576A1 | Canada | A1 | |
| CA2448623A1 | Canada | A1 | |
| CA2448630A1 | Canada | A1 | |
| WO9831361A1 | World Intellectual Property Organization (WIPO) | A1 | |
| FR2758459A1 | France | A1 | |
| AU5336798A | Australia | A | |
| ZA98324B | South Africa | B | |
| FR2758459B1 | France | B1 | |
| IS5097A | Iceland | A | |
| NO993519D0 | Norway | D0 | |
| NO20100034L | Norway | L | |
| NO993519L | Norway | L | |
| TR199901660T2 | Türkiye | T2 | |
| ID22528A | Indonesia | A | |
| EP0952829A1 | European Patent Office (EPO) | A1 | |
| CZ253599A3 | Czechia | A3 | |
| CN1243438A | China | A | |
| EE9900296A | Estonia | A | |
| BR9806738A | Brazil | A | |
| PL334748A1 | Poland | A1 | |
| US6074670A | United States of America | A | |
| SK96299A3 | Slovakia | A3 | |
| AR011411A1 | Argentina | A1 | |
| HK1023071A1 | Hong Kong, China | A1 | |
| NZ336462A | New Zealand | A | |
| KR20000070021A | Republic of Korea | A | |
| HU0000808A2 | Hungary | A2 | |
| HUP0000808A2 | Hungary | A2 | |
| IL130790D0 | Israel | D0 | |
| HU0000808A3 | Hungary | A3 | |
| HUP0000808A3 | Hungary | A3 | |
| AU731964B2 | Australia | B2 | |
| JP2001511156A | Japan | A | |
| US6277405B1 | United States of America | B1 | |
| US2002009496A1 | United States of America | A1 | |
| CA2219475C | Canada | C | |
| IN187906B | India | B | |
| US2002114839A1 | United States of America | A1 | |
| US2002168413A1 | United States of America | A1 | |
| EP1273293A1 | European Patent Office (EPO) | A1 | |
| EP1273294A1 | European Patent Office (EPO) | A1 | |
| EP1275387A1 | European Patent Office (EPO) | A1 | |
| RU2196580C2 | Russian Federation | C2 | |
| EP0952829B1 | European Patent Office (EPO) | B1 | |
| AT233556T | Austria | T | |
| ATE233556T1 | Austria | T1 | |
| DE69811855D1 | Germany | D1 | |
| DZ2398A1 | Algeria | A1 | |
| US2003104051A1 | United States of America | A1 | |
| US2003104060A1 | United States of America | A1 | |
| EE04042B1 | Estonia | B1 | |
| DK0952829T3 | Denmark | T3 | |
| US6589552B2 | United States of America | B2 | |
| KR100391104B1 | Republic of Korea | B1 | |
| US6596317B2 | United States of America | B2 | |
| PT952829E | Portugal | E | |
| UA61096C2 | Ukraine | C2 | |
| US6652881B2 | United States of America | B2 | |
| ES2195308T3 | Spain | T3 | |
| DE69811855T2 | Germany | T2 | |
| KR100415897B1 | Republic of Korea | B1 | |
| CA2372576C | Canada | C | |
| RU2002109746A | Russian Federation | A | |
| US2004057997A1 | United States of America | A1 | |
| US2004057998A1 | United States of America | A1 | |
| US2004057999A1 | United States of America | A1 | |
| US2004058004A1 | United States of America | A1 | |
| US2004058005A1 | United States of America | A1 | |
| HU0400409D0 | Hungary | D0 | |
| US2004092597A1 | United States of America | A1 | |
| CN1496738A | China | A | |
| CY2396B1 | Cyprus | B1 | |
| RU2236850C2 | Russian Federation | C2 | |
| EP1468681A1 | European Patent Office (EPO) | A1 | |
| RU2238089C2 | Russian Federation | C2 | |
| DE29825080U1 | Germany | U1 | |
| MA26466A1 | Morocco | A1 | |
| HK1065952A1 | Hong Kong, China | A1 | |
| TNSN98009A1 | Tunisia | A1 | |
| EP1273293B1 | European Patent Office (EPO) | B1 | |
| AT291911T | Austria | T | |
| ATE291911T1 | Austria | T1 | |
| DE69829591D1 | Germany | D1 | |
| DK1273293T3 | Denmark | T3 | |
| PT1273293E | Portugal | E | |
| JP2005206614A | Japan | A | |
| EP1273294B1 | European Patent Office (EPO) | B1 | |
| ES2241931T3 | Spain | T3 | |
| AT307576TThis record | Austria | T | |
| ATE307576T1 | Austria | T1 | |
| DE69832108D1 | Germany | D1 | |
| CY2513B1 | Cyprus | B1 | |
| DE69829591T2 | Germany | T2 | |
| DK1273294T3 | Denmark | T3 | |
| US7037529B2 | United States of America | B2 | |
| EP1275387B1 | European Patent Office (EPO) | B1 | |
| US7041319B2 | United States of America | B2 | |
| DE69834437D1 | Germany | D1 |
Showing 100 of 144
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 2018029
Titles2
- German
- FENOFIBRATHALTIGE ARZNEIZUSAMMENSETZUNG MIT ERHÖHTER BIOVERFÜGBARKEIT UND VERFAHREN ZU DEREN HERSTELLUNG
- English
- FENO-FIBRATED MEDICAMENTIC COMPOSITION WITH INCREASED BIOAVAILABILITY AND METHOD FOR THE PRODUCTION THEREOF
Classification
- CPC, 16
- A61K9/1676
- A61K31/215
- A61K9/14
- A61K9/1617
- A61K9/1623
- A61K9/1635
- A61K9/2027
- A61K9/2054
- A61K9/2077
- A61K9/2081
- A61K31/12
- A61K31/216
- A61P1/18
- A61P3/04
- A61P3/06
- A61K9/16
- IPC, 24
- A61K9 00
- A61K9 10
- A61K9 16
- A61K9 20
- A61K9 22
- A61K9 26
- A61K9 48
- A61K9 52
- A61K9 54
- A61K9 58
- A61K31 215
- A61K31 216
- A61K47 12
- A61K47 14
- A61K47 20
- A61K47 24
- A61K47 26
- A61K47 28
- A61K47 32
- A61K47 34
- A61K47 38
- A61K47 42
- A61P3 04
- A61P3 06